Does ghrelin come back after gastric sleeve surgery? It is one of the most common questions patients ask following a sleeve gastrectomy, and the answer has real implications for long-term weight management. Ghrelin — the body's primary hunger hormone — is produced mainly in the fundus of the stomach, the very tissue removed during the procedure. Understanding how ghrelin levels change after surgery, what the evidence says about their long-term trajectory, and how to manage appetite effectively can help patients and clinicians make informed decisions about post-operative care and support.

What Is Ghrelin and How Does It Affect Hunger?

Ghrelin is a peptide hormone produced primarily in the stomach's fundus that signals hunger to the hypothalamus; in obesity, post-meal ghrelin suppression is blunted, contributing to persistent hunger.

Ghrelin is often referred to as the 'hunger hormone' — a peptide hormone produced primarily in the fundus of the stomach, though smaller amounts are also produced in the small intestine and pancreas. It plays a central role in appetite regulation by signalling to the hypothalamus that the body needs food. Ghrelin levels typically rise before meals and fall after eating, making it one of the key drivers of short-term hunger and meal initiation.

Beyond appetite, ghrelin also influences a range of metabolic processes, including:

• Energy balance and fat storage — higher ghrelin levels are associated with increased caloric intake and reduced fat breakdown

• Blood glucose regulation — ghrelin can affect insulin sensitivity and glucose metabolism

• Gut motility — it plays a role in stimulating gastric emptying and digestive activity

In individuals with obesity, ghrelin dynamics are often altered. Fasting ghrelin levels may actually be lower than in people of a healthy weight, but the normal suppression of ghrelin after meals is blunted — meaning hunger signals do not reduce as effectively following eating. This impaired post-meal suppression can contribute to persistent feelings of hunger and difficulty maintaining dietary changes. Understanding how ghrelin behaves is therefore particularly relevant when considering bariatric interventions such as the gastric sleeve, which directly affects the tissue responsible for producing most of this hormone.

How Gastric Sleeve Surgery Affects Ghrelin Levels

Sleeve gastrectomy removes the fundus — the main ghrelin-producing tissue — causing a substantial drop in circulating ghrelin levels in the weeks and months following surgery.

The gastric sleeve procedure — formally known as a sleeve gastrectomy — involves the surgical removal of approximately 75–80% of the stomach, leaving a narrow, tube-shaped 'sleeve'. Crucially, the portion of the stomach that is removed includes the fundus, which is the primary site of ghrelin production. This anatomical change has a direct and significant impact on circulating ghrelin levels.

In the immediate post-operative period, most patients experience a marked reduction in ghrelin concentrations. Studies consistently show that ghrelin levels drop substantially in the weeks and months following sleeve gastrectomy, which is thought to contribute to the reduced appetite many patients report after surgery. This hormonal shift is considered one of the key mechanisms by which the gastric sleeve supports weight loss — not simply by restricting food intake, but by altering the hormonal signals that drive hunger.

It is worth noting that the degree of ghrelin reduction can vary between individuals, and is influenced by surgical technique, the extent of fundal tissue removed, and other anatomical factors. This is distinct from adjustable gastric band surgery, which does not remove stomach tissue and therefore does not produce the same reduction in ghrelin. The gastric sleeve's impact on ghrelin is one of the reasons it is generally associated with greater weight loss compared to adjustable gastric banding. However, the long-term trajectory of ghrelin levels after sleeve gastrectomy is more complex, and this is where patient questions about returning hunger become particularly relevant.

For further information on the procedure and its expected effects, the NHS weight loss surgery pages provide a helpful patient-facing overview.

What the Evidence Says About Long-Term Appetite Changes

Ghrelin is significantly suppressed in the first 12–24 months post-surgery but may gradually recover thereafter, with some patients approaching pre-operative levels by three to five years.

The question of whether ghrelin comes back after gastric sleeve surgery is one that researchers have studied with considerable interest. The evidence suggests that ghrelin levels do tend to rise again over time in many patients, though findings vary across studies and individuals. Levels generally remain lower than pre-operative values in some patients, whilst others show a more substantial recovery. This variability reflects differences in surgical technique, the extent of fundal resection, and individual biological factors.

Several longitudinal studies have demonstrated that whilst ghrelin is significantly suppressed in the first 12–24 months post-surgery, levels may begin to gradually increase thereafter. By three to five years post-operatively, some patients show ghrelin concentrations approaching — though not always reaching — their pre-surgical baseline, whilst others maintain more sustained suppression.

It is important to emphasise that weight regain after sleeve gastrectomy is multifactorial. Partial ghrelin recovery is one contributing factor among several, including behavioural adaptation, changes in sleeve size over time, psychosocial factors, and shifts in other appetite-regulating hormones. Other gut hormones, including GLP-1 (glucagon-like peptide-1) and peptide YY (PYY), which promote satiety, are also altered by sleeve gastrectomy and may help to offset the effects of rising ghrelin over time. The overall picture is therefore nuanced:

• Short term (0–12 months): Ghrelin significantly suppressed in most patients; appetite notably reduced

• Medium term (1–3 years): Ghrelin may begin to recover in some individuals; appetite can gradually increase

• Long term (3+ years): Ghrelin levels may approach pre-operative values in some patients; hunger patterns vary widely

This evidence underscores the importance of ongoing support and lifestyle management beyond the initial post-operative period.

Managing Hunger and Weight After Gastric Sleeve Surgery

Long-term success after gastric sleeve requires a multidisciplinary approach including high-protein eating, regular physical activity, lifelong supplementation, and ongoing follow-up with a bariatric team.

Understanding that ghrelin may partially recover over time is not a reason for concern, but rather a prompt to engage proactively with long-term management strategies. Bariatric surgery is most effective when combined with sustained behavioural, nutritional, and psychological support — a principle reflected in NICE guidance on obesity management (CG189), which emphasises that surgical interventions should be part of a comprehensive, multidisciplinary care pathway.

Practical strategies to manage hunger and support long-term weight maintenance after gastric sleeve surgery include:

• Prioritising protein at each meal — protein is the most satiating macronutrient and helps preserve lean muscle mass during weight loss

• Eating mindfully and slowly — the reduced stomach capacity means eating too quickly can lead to discomfort and may bypass natural satiety signals

• Staying well hydrated — thirst is sometimes misinterpreted as hunger; fluid intake targets and the timing of drinking in relation to meals should follow the staged plan provided by your bariatric team, as recommendations evolve across the different post-operative phases

• Regular physical activity — exercise supports metabolic health and can help regulate appetite hormones over time

• Lifelong micronutrient supplementation and blood monitoring — sleeve gastrectomy affects nutrient absorption; the British Obesity and Metabolic Surgery Society (BOMSS) recommends lifelong multivitamin and mineral supplementation alongside scheduled blood tests to monitor for nutritional deficiencies. Your bariatric team will advise on the specific supplements and monitoring schedule appropriate for you

• Attending follow-up appointments — regular reviews with a dietitian and bariatric team allow for early identification of dietary drift, nutritional deficiencies, or weight regain

For some patients, pharmacological support may be considered if weight regain becomes clinically significant. In the UK, NICE has appraised several medicines for weight management: liraglutide 3.0 mg (Saxenda®, NICE TA664) and semaglutide 2.4 mg (Wegovy®, NICE TA875) are GLP-1 receptor agonists licensed for weight management, each with specific eligibility criteria and a requirement for access through specialist weight-management services. Any decision about pharmacological treatment should be made in consultation with a qualified healthcare professional and in line with current NICE guidance and the relevant Summary of Product Characteristics (SmPC).

When to Speak to Your Bariatric Team About Appetite Concerns

Contact your bariatric team if you experience rapid early return of hunger, persistent reflux, significant weight regain, nutritional symptoms, or psychological distress related to eating.

It is entirely normal to notice changes in appetite in the months and years following gastric sleeve surgery. A gradual return of hunger, particularly after the first year, does not necessarily indicate a problem — but it is important to distinguish between expected hormonal changes and signs that may warrant clinical review.

You should contact your bariatric team or GP if you experience any of the following:

• Significant and rapid return of hunger within the first few months post-surgery — this may reflect anatomical or technical factors and warrants assessment by your surgical team

• Persistent nausea, vomiting, or worsening reflux — this may indicate a complication such as sleeve dilation or gastro-oesophageal reflux disease (GORD) and should be reviewed promptly

• Unintended weight regain of more than 10–15% of your lowest post-operative weight, particularly if accompanied by increased appetite

• Emotional or psychological distress related to eating, body image, or food behaviours — psychological support is a recognised and important component of post-bariatric care

• Nutritional symptoms such as persistent fatigue, hair loss, or muscle weakness, which may indicate deficiencies requiring supplementation review

If you experience severe abdominal pain, persistent vomiting with signs of dehydration, or any gastrointestinal bleeding, seek urgent medical attention — contact your bariatric team urgently, attend an urgent treatment centre, or call 999 if symptoms are severe.

Not sure if this is normal? Chat with one of our pharmacists →

BOMSS recommends a minimum of two years of specialist follow-up after bariatric surgery, followed by ongoing annual monitoring in primary care. Patients are encouraged to remain engaged with their care team rather than waiting until concerns become significant. Early intervention — whether dietary, psychological, or medical — is consistently associated with better long-term outcomes. If you are unsure who to contact, your GP can refer you back to your surgical team or to a specialist obesity service.

Frequently Asked Questions